Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. reports developments tied to its national home health and hospice care business in the United States. The company’s Home Health segment provides Medicare-certified nursing, therapy, medical social work and aide services for adult patients, while its Hospice segment focuses on care for patients with life-limiting illnesses.
Recurring Enhabit news includes quarterly operating results, home health admissions and census trends, hospice performance, debt reduction and credit-related actions, investor presentations, material agreements, shareholder voting matters and governance updates. Company updates also cover legal and regulatory disclosures when they affect its public-company reporting or corporate matters.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has received the Great Place To Work Certification™ for 2025. The certification is based on current employee feedback, with 83% of employees rating it as a great workplace - 26 points above the U.S. company average.
The company operates across 34 states with 256 home health locations and 112 hospice locations, employing over 10,000 staff. Enhabit offers competitive benefits, flexible schedules, professional development, and advanced technology to support patient care. As one of the largest Medicare-certified providers in the nation, the company focuses on expanding possibilities for home-based patient care.
Encompass Health and Enhabit have won a significant lawsuit in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The Court also ruled against private equity firms Vistria Group and Nautic Partners for aiding these breaches.
The Court found that the defendants misappropriated acquisition opportunities, used confidential information, and recruited key employees while still employed at Encompass Health. As compensation, the Court awarded 43% of VitalCaring Group's profits to Encompass Health and Enhabit, plus $1.62 million in mitigation damages and attorneys' fees.
The defendants were found to have deliberately concealed their actions through falsifying records, deleting evidence, and manipulating communications. The Court's decision sends a clear message about the consequences of breaching fiduciary duties and self-dealing by corporate officers.
Encompass Health and Enhabit have won a significant legal victory in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The court found that while employed at Encompass Health, these officers misappropriated acquisition opportunities, used confidential information, and recruited employees for a competing venture.
The Court awarded damages against private equity firms Vistria Group and Nautic Partners for aiding these breaches. The remedy includes a constructive trust entitling Encompass Health and Enhabit to 43% of VitalCaring Group's profits and future exit proceeds, approximately $1.62 million in mitigation damages, and attorneys' fees due to defendants' bad faith conduct including evidence tampering.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, announced its participation in the BofA Securities 2024 Home Care Conference. President and CEO Barb Jacobsmeyer, incoming CFO Ryan Solomon, and SVP of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The event will be webcast live and available for replay on the company's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, leveraging advanced technology for patient care delivery.
Enhabit Home Health & Hospice (NYSE: EHAB) has appointed Ryan Solomon as its new Chief Financial Officer, effective Dec. 9, 2024. Solomon brings over 20 years of corporate strategy and finance experience, including eight years as CFO in home health and hospice. He previously served as CFO at AccentCare and Aspirion, where he managed financial planning, accounting, tax, treasury, revenue cycle, and corporate development. Solomon will replace Crissy Carlisle, the current CFO, as part of a previously announced transition. His experience includes building finance teams, systems integration, mergers and acquisitions, and operational business planning.
Enhabit Inc (NYSE: EHAB) reported Q3 2024 financial results with net service revenue of $253.6 million, down 1.8% year-over-year. The company reported a net loss of $110.2 million and Adjusted EBITDA of $24.5 million, up 5.6%. Home health segment saw non-Medicare admissions increase 20.1%, while hospice segment revenue grew 11% with average daily census up 6.9%. Due to lower recertifications and hurricane impacts, Enhabit revised its full-year 2024 guidance, with net service revenue now expected between $1,031-$1,046 million and Adjusted EBITDA between $98-$102 million.
Enhabit Home Health & Hospice (NYSE: EHAB) has been recognized as an Age-Friendly Health Systems Participant by the Institute for Healthcare Improvement (IHI). This recognition acknowledges Enhabit's commitment to implementing the 4Ms of Age-Friendly Care: What Matters, Medication, Mentation, and Mobility.
Bud Langham, executive vice president of clinical excellence & strategy at Enhabit, emphasized the company's dedication to providing the best possible care for older adults. The Age-Friendly Health Systems initiative, supported by The John A. Hartford Foundation and other partners, aims to improve care for older adults across various healthcare settings, including home-based care.
By participating in this movement, Enhabit joins a select group of healthcare systems worldwide working to tailor care to patients' goals and preferences, aligning with their vision of excellence in elder care.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, has announced its participation in two upcoming investor conferences. The company's President and CEO Barb Jacobsmeyer and CFO Crissy Carlisle will attend:
- Jefferies Healthcare Services "Back to School" Summit and Bus Tour on Aug. 28 in Nashville, Tenn.
- 2024 Wells Fargo Healthcare Conference on Sept. 5 in Boston, Mass., including investor meetings and a fireside chat.
The fireside chat will be webcast live at 11 a.m. EDT and available for replay on Enhabit's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, focusing on expanding patient care possibilities in the home through advanced technology and compassionate teams.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, has announced that CFO Crissy Carlisle will step down from her role. The company has initiated a comprehensive search for her successor. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities.
CEO Barb Jacobsmeyer praised Carlisle's contributions since Enhabit became a public company two years ago, highlighting her role in achieving business stability and positioning the organization for growth. Carlisle expressed pride in her accomplishments, including establishing a finance organization and enhancing the control environment.
Enhabit operates 256 home health locations and 112 hospice locations across 34 states. The company will hold a conference call to discuss its second quarter 2024 financial results.
Enhabit, Inc. (NYSE: EHAB) reported its Q2 2024 financial results, showing mixed performance across its home health and hospice segments. Key highlights include:
- Net service revenue of $260.6 million, down 0.6% year-over-year
- Net loss of $0.2 million, improved from a $74.4 million loss in Q2 2023
- Adjusted EBITDA of $25.2 million, up 5.4% year-over-year
- Earnings per share of $0.00, adjusted EPS of $0.07
The home health segment saw a 6.4% increase in total admissions, driven by a 25.2% growth in non-Medicare admissions. Hospice segment revenue grew 3.9%, with average daily census increasing 2.7% year-over-year. The company updated its full-year 2024 guidance, slightly lowering revenue expectations but maintaining its adjusted EBITDA forecast.